glp-1 craze Retatrutide isn't supposed to be everywhere., Touted as the next generation in the craze, it's an experimental weight-loss drug that is not authorized outside of clinical trials. The Food and Fast food goes GLP-1: Shake

doi: 10.1210/clinem/dgab359

Susana Monereo destaca la trascendencia de estos avances: "Los frmacos actuales son un hito, pues modulan a nivel cerebral los mecanismos de regulacin del hambre y la saciedad, ofreciendo as un nuevo paradigma en el manejo de la obesidad." Los tratamientos farmacolgicos modernos para la obesidad incluyen agentes que actan directamente sobre los centros de hambre y saciedad en el cerebro y alteran las vas metablicas para reducir el almacenamiento de grasa y aumentar el gasto energtico

The evidence, pricing, and purpose are not the same

Cleveland Clinic describes GLP-1 agonists as a class of medications that mainly help manage blood sugar levels for people with T2D, but notes that due to the drugs satiety effect, they can often promote weight loss

Main Citation "3

The data revealed that women whod taken a GLP-1 had lower odds of negative maternal outcomes compared with the women taking other diabetes medications